Exciting change is on the way! Please join us at nsf.gov for the latest news on NSF-funded research. While the NSF Science360 page and daily newsletter have now been retired, there’s much happening at nsf.gov. You’ll find current research news on the homepage and much more to explore throughout the site. Best of all, we’ve begun to build a brand-new website that will bring together news, social media, multimedia and more in a way that offers visitors a rich, rewarding, user-friendly experience.

Want to continue to receive email updates on the latest NSF research news and multimedia content? On September 23rd we’ll begin sending those updates via GovDelivery. If you’d prefer not to receive them, please unsubscribe now from Science360 News and your email address will not be moved into the new system.

Thanks so much for being part of the NSF Science360 News Service community. We hope you’ll stay with us during this transition so that we can continue to share the many ways NSF-funded research is advancing knowledge that transforms our future.

For additional information, please contact us at NewsTravels@nsf.gov

Today's Video

Dogs and humans with diabetes may get relief from frequent injections

An engineering breakthrough in Type 1 diabetes could help dogs and humans alike. The disease affects about one in every 100 companion animals in the U.S., including dogs and cats, and approximately 1.25 million American children and adults. Purdue engineers in collaboration with the Indiana University School of Medicine, with funding from the National Science Foundation, are developing a new therapy that could replace the need for daily insulin injections for both canines and humans. The therapy has the potential to reduce the number of shots to one every few months. This breakthrough could make managing the disease much easier.

Provided by National Science Foundation
Runtime: 1:01